Finance

Lists
Q3 2026 earnings • released • EPS miss -10,96% • Revenue beat +2,79%
See results
6472:TPE
Bora Pharmaceuticals Co Ltd
NT$402,00
+0,25%
(+1,00) 1D
13 Nov., 13:30:19 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6472...
Open
NT$402,50
High
NT$416,00
Low
NT$398,00
Mkt. cap
51,46 mjd
Avg. vol.
686,57 k
Volume
764,44 k
P/E ratio
32,99
52-wk high
NT$646,00
52-wk low
NT$330,50
EPS
NT$12,19
No. of employees
36
Open
NT$402,50
High
NT$416,00
Low
NT$398,00
Mkt. cap
51,46 mjd
Avg. vol.
686,57 k
Volume
764,44 k
P/E ratio
32,99
52-wk high
NT$646,00
52-wk low
NT$330,50
EPS
NT$12,19
No. of employees
36
News stories
From web sources and news partners
About Bora Pharmaceuticals Co Ltd
CEOBobby Sheng
Employees36
Founded2007
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitebora-corp.com
Last report
13 Nov. 2026
Fiscal period
Q3 2026
NT$4,66 / NT$5,23
-10,96%miss
Revenue / Est. (TWD)
6,45 mjd / 6,28 mjd
+2,79%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
4,81 mjd
4,86 mjd
4,00 mjd
5,89 mjd
Cost of goods sold
2,63 mjd
3,09 mjd
2,56 mjd
3,46 mjd
Cost of revenue
2,63 mjd
3,09 mjd
2,56 mjd
3,46 mjd
Research and development expenses
147,09 m
181,25 m
167,93 m
190,74 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
961,21 m
1,03 mjd
866,09 m
1,25 mjd
Operating expense
1,11 mjd
1,22 mjd
1,04 mjd
1,44 mjd
Total operating expenses
3,74 mjd
4,30 mjd
3,59 mjd
4,90 mjd
Operating income
1,06 mjd
556,34 m
407,24 m
986,64 m
Other non operating income
36,54 m
15,19 m
24,01 m
-15,28 m
EBT including unusual items
895,42 m
809,67 m
221,15 m
813,10 m
EBT excluding unusual items
926,44 m
375,02 m
222,24 m
788,94 m
Income tax expense
73,70 m
381,93 m
174,25 m
205,59 m
Effective tax rate
8,23%
47,17%
78,79%
25,28%
Other operating expenses
396,00 k
1,24 m
1,37 m
-
Net income
633,61 m
331,76 m
25,84 m
555,76 m
Net profit margin
13,18%
6,83%
0,65%
9,44%
Earnings per share
4,99
2,78
0,20
4,24
Interest and investment income
2,67 m
10,49 m
6,25 m
11,16 m
Interest expense
-125,12 m
-122,01 m
-113,73 m
-124,33 m
Net interest expenses
-122,44 m
-111,52 m
-107,48 m
-113,17 m
Depreciation and amortization charges
-
-
-
-
EBITDA
1,28 mjd
784,95 m
634,54 m
1,27 mjd
Gain or loss from assets sale
-10,15 m
1,32 m
63,00 k
2,00 k
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme